← back to search

Yan Li

Centers for Disease Control and Prevention · US
Area of research
Molecular Medicine · Ecology
Research interest
Research interests include Antibiotic Resistance in Bacteria, Bacteriophages and microbial interactions, Hepatitis B Virus Studies, and Immune Response and Inflammation.
h-index
46
citations
10,605
works
280
NIH funding
primary concept
email

Recent publications

Hetrombopag for patients with persistent primary immune thrombocytopenia: A post-hoc analysis of a multicenter, randomized phase Ⅲ Trial
Blood 2025cited by 0position: middledoi
A refined therapeutic plan based on the machine-learning prognostic model of liver hepatocellular carcinoma
Computers in Biology and Medicine 2024cited by 7position: contributordoi
CACA guidelines for holistic integrative management of adult acute myeloid leukemia
Holistic Integrative Oncology 2024cited by 3position: middledoi
A gB nanoparticle vaccine elicits a protective neutralizing antibody response against EBV
Cell Host & Microbe 2023cited by 66position: middledoi
Global distribution and genomic characteristics of carbapenemase-producing Escherichia coli among humans, 2005–2023
Drug Resistance Updates 2023cited by 52position: firstdoi
Global distribution and genomic characteristics of tet(X)-positive Escherichia coli among humans, animals, and the environment
The Science of The Total Environment 2023cited by 39position: firstdoi
Sovleplenib (HMPL-523), a novel Syk inhibitor, for patients with primary immune thrombocytopenia in China: a randomised, double-blind, placebo-controlled, phase 1b/2 study
The Lancet Haematology 2023cited by 22position: middledoi
Switching from Eltrombopag to Hetrombopag in Patients with Primary Immune Thrombocytopenia (ITP): Post-Hoc Analysis of a Multicenter, Randomized Phase III Trial
Blood 2022cited by 1position: middledoi
A multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopenia
Journal of Hematology & Oncology 2021cited by 72position: middledoi
LS‐106, a novel EGFR inhibitor targeting C797S, exhibits antitumor activities both in vitro and in vivo
Cancer Science 2021cited by 51position: middledoi
High-throughput screening and evaluation of repurposed drugs targeting the SARS-CoV-2 main protease.
2021cited by 6position: contributordoi
Multi-system neurological disorder associated with a CRYAB variant
Neurogenetics 2021cited by 3position: middledoi
Serum IL‐36 cytokines levels in type 2 diabetes mellitus patients and their association with obesity, insulin resistance, and inflammation
Journal of Clinical Laboratory Analysis 2020cited by 27position: firstdoi
The discovery of potent immunostimulatory CpG-ODNs widely distributed in bacterial genomes.
2020cited by 4position: contributordoi
ZBTB38, a novel regulator of autophagy initiation targeted by RB1CC1/FIP200 in spinal cord injury
Gene 2018cited by 9position: middledoi
Genome sequence and genetic diversity of the common carp, Cyprinus carpio
Nature Genetics 2014cited by 668position: middledoi

Grants

EPSCOR Research Fellows: NSF: Multifunctional Metamaterial Design for Future Electric Vertical Take-off and Landing Aircrafts
NSF2531663$300,0002026–2027PIRePORTER
Collaborative Research: Chimeric Antigen Receptor Engineered Neutrophil Extracellular Vesicles Targeting Glioblastoma
NSF2425703$350,0002025–2028PIRePORTER
Collaborative Research: Variational Quantum Technology for Seamless Transition Between Grid-Following and Grid-Forming Controls for Inverter-Based Resources
NSF2413237$275,0002025–2027PIRePORTER
CyberTraining: Pilot: Immersive and Collaborative Quantum Computing Training for Power System Engineers
NSF2417773$300,0002024–2027PIRePORTER
AMPS: Compositional Data-Driven Modeling, Prediction and Control for Reconfigurable Renewable Energy Systems
NSF2229435$429,1582022–2025PIRePORTER
Human Stem Cell Fate Decisions Dictated by Decoupled Biophysical Cues
NSF1917618$510,0002020–2024PIRePORTER
CAREER:Engineering Brain-region-specific Organoids Derived from Human Stem Cells
NSF1652992$611,3402017–2024PIRePORTER
Collaborative Research: Maintaining Energy Homeostasis to Preserve Biological Properties during Culture Expansion of Human Mesenchymal Stem Cells
NSF1743426$607,9722017–2022PIRePORTER
Conference on Frontiers of Hierarchical Modeling in Observational Studies, Complex Surveys and Big Data, May 29-31, 2014
NSF1361869$10,0002014–2015PIRePORTER
The Origins and Implications of Solar Flare and CME-Related Magnetic Field Changes
NSF1249150$439,0922013–2016PIRePORTER
BRIGE: Engineering a BioMatrix Library Derived from Induced Pluripotent Stem Cells
NSF1342192$174,7372013–2017PIRePORTER
Quantifying Solar Magnetic Field Evolution and Its Relation to Eruptions
NSF0451438$297,3712005–2008PIRePORTER
SBIR Phase I: Micro/Nanofluidic Protein Profiler for Pathogen Detection
NSF0441585$100,0002005–2005PIRePORTER
Space Weather: Applications of Global Oscillations Network Group (GONG+) Magnetograms
NSF0208500$146,2292002–2004PIRePORTER

Frequent collaborators

· 2 papers (2023–2023)Ruichao Li · Medical College of Wisconsin2 papers (2023–2023)Zhiqiang Wang · Shandong University2 papers (2023–2023)Xiaofan Liu · Huazhong University of Science and Technology1 papers (2023–2023)Wen-Ming Chen · Wenzhou Medical University1 papers (2023–2023)Jie Chen · Nanjing Agricultural University1 papers (2018–2018)Ying Hu · University of Florida1 papers (2021–2021)Yan Fang · Ludong University1 papers (2021–2021)Hao Chen · University of California, San Francisco1 papers (2021–2021)Hua Xie · Soochow University1 papers (2021–2021)Haosen Wang · Guangdong University of Technology1 papers (2018–2018)Chaofeng Xing · Guangdong University of Technology1 papers (2018–2018)Xia Xiao · South China Agricultural University1 papers (2023–2023)Peiran Song · Shanghai University1 papers (2021–2021)Weiguo Su · China Banking Regulatory Commission1 papers (2023–2023)Chengwei Luo · Georgia Institute of Technology1 papers (2023–2023)Chengyuan Gu · Shanghai Medical College of Fudan University1 papers (2023–2023) · 1 papers (2024–2024)Jie Yin · Shandong University1 papers (2023–2023) · 1 papers (2021–2021)